Dimerix Stock

Dimerix FCF/Debt

The Free Cash Flow to Debt Ratio of Dimerix (DXB.AX) as of Sep 4, 2026 is 40,032.31 %. In the previous year, Free Cash Flow to Debt Ratio was -4,689.25 % — a change of -953.70% (higher).

FCF/Debt

40,032.31 %

YoY

-953.70%

Last updated:

Free Cash Flow to Debt Ratio of Dimerix is 2026 40,032.31 % . Free Cash Flow to Debt Ratio of Dimerix was 2025 -4,689.25 % . It decreases by -953.70% higher compared to the previous year.

The Dimerix FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2020
-431.46 AUD
Jan 1, 2021
-125.07 AUD
Jan 1, 2022
-18,394.66 AUD
Jan 1, 2023
-213.69 AUD
Jan 1, 2024
-4,689.25 AUD
Jan 1, 2025
40,032.31 AUD
The Dimerix FCF/Debt history
YEARFCF/DebtYoY
40,032.31 %-953.70%
-4,689.25 %+2,094.45%
-213.69 %-98.84%
-18,394.66 %+14,607.36%
-125.07 %-71.01%
-431.46 %
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Free Cash Flow to Debt Ratio of Dimerix is 40,032.31 % in 2026.

Free Cash Flow to Debt Ratio of Dimerix changed from -4,689.25 % to 40,032.31 %, representing a -953.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Dimerix since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Dimerix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Dimerix

All Key Metrics — Dimerix